1. |
Scheffer IE, Liao JX. Deciphering the concepts behind "Epileptic encephalopathy" and "Developmental and epileptic encephalopathy". Eur J Paediatr Neurol, 2020, 24: 11-14.
|
2. |
Specchio N, Curatolo P. Developmental and epileptic encephalopathies what we do and do not know. Brain, 2021, 144(1): 32-43.
|
3. |
Matricardi S, Cestèle S, Trivisano M, et al. Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication. Epilepsia, 2023, 64(5): 1331-1347.
|
4. |
Morrison-Levy N, Borlot F, Jain P, et al. Early-onset developmental and epileptic encephalopathies of infancy: an overview of the genetic basis and clinical features. Pediatr Neurol, 2021, 116: 85-94.
|
5. |
Knowles JK, Helbig I, Metcalf CS, et al. Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress. Epilepsia, 2022, 63(10): 2461-2475.
|
6. |
de la Torre A. The genetics of epilepsy in the clinical practice. Medicina (B Aires), 2023, 83(Suppl 4): 9-12.
|
7. |
Bayat A, Bayat M, Rubboli G, et al. Epilepsy syndromes in the first year of life and usefulness of genetic testing for precision therapy. Genes (Basel), 2021, 812(7): 1051.
|
8. |
Brunklaus A, Lal D. Sodium channel epilepsies and neurodevelopmental disorders: From disease mechanisms to clinical application. Dev Med Child Neurol, 2020, 62(7): 784-792.
|
9. |
von Wrede R, Jeub M, Ariöz I, et al. Novel KCNH1 mutations associated with epilepsy: broadening the phenotypic spectrum of KCNH1-associated diseases. Genes (Basel), 2021, 21: 12(2)-132.
|
10. |
Sampedro-Castañeda M, Baltussen LL, Lopes AT, et al. Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2. 3, altering inactivation kinetics and neuronal excitability. Nat Commun, 2023, 1114(1): 7830.
|
11. |
金良, 陈语婕, 陈勇军. 发育性和癫痫性脑病遗传性病因及诊疗的研究进展. 遗传, 2023, 45(7): 553-567.
|
12. |
Scott RC. Brains, complex systems and therapeutic opportunities in epilepsy. Seizure, 2021, 90: 155-159.
|
13. |
Yu W, Hill SF, Xenakis JG, et al. Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouse. Epilepsia, 2020, 61(12): 2847-2856.
|
14. |
Shaimardanova AA, Chulpanova DS, Mullagulova AI, et al. Gene and cell therapy for epilepsy: a mini review. Front Mol Neurosci, 2022, 11;15: 868531.
|
15. |
Previtali R, Prontera G, Alfei E, et al. Paradigm shift in the treatment of tuberous sclerosis: Effectiveness of everolimus. Pharmacol Res, 2023, 195: 106884.
|
16. |
Lechuga L, Franz DN. Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizures. Expert Rev Neurother, 2019, 19(10): 913-925.
|
17. |
Overwater IE, Rietman AB, van Eeghen AM, et al. Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives. Ther Clin Risk Manag, 2019, 15: 951-955.
|
18. |
Johannessen Landmark C, Potschka H, Auvin S, et al. The role of new medical treatments for the management of developmental and epileptic encephalopathies: Novel concepts and results. Epilepsia, 2021, 62(4): 857-873.
|
19. |
Privitera M, Bhathal H, Wong M, et al. Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: analysis from two randomized controlled trials. Epilepsia, 2021, 62(5): 1130-1140.
|
20. |
Specchio N, Pietrafusa N, Doccini V, et al. Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a real-world study. Epilepsia, 2020, 61(11): 2405-2414.
|
21. |
Balagura G, Cacciatore M, Grasso EA, et al. Fenfluramine for the treatment of Dravet syndrome and Lennox–Gastaut syndrome. CNS Drugs, 2020, 34(10): 1001-1007.
|
22. |
Devinsky O, King L, Schwartz D, et al. Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder. Epilepsia, 2021, 62(7): 98-102.
|
23. |
Shcheglovitov A, Peterson RT. Screening platforms for genetic epilepsies-zebrafish, ipsc-derived neurons, and organoids. Neurotherapeutics, 2021, 18(3): 1478-1489.
|
24. |
Hirose S, Tanaka Y, Shibata M, et al. Application of induced pluripotent stem cells in epilepsy. Mol Cell Neurosci, 2020, 108: 103535.
|
25. |
Palmer EE, Howell K, Scheffer IE, et al. Natural history studies and clinical trial readiness for genetic developmental and epileptic encephalopathies. Neurotherapeutics, 2021, 18(3): 1432-1444.
|
26. |
Tidball AM, Lopez-Santiago LF, Yuan Y, et al. Variant-specific changes in persistent or resurgent sodium current in SCN8A-related epilepsy patient-derived neurons. Brain, 2020, 143(10): 3025-3040.
|
27. |
Gordon A, Yoon SJ, Tran SS, et al. Long-term maturation of human cortical organoids matches key early postnatal transitions. Nat Neurosci, 2021, 24(3): 331-342.
|
28. |
Morris G, Rowell R, Cunningham M, et al. Limitations of animal epilepsy research models: Can epileptic human tissue provide translational benefit? ALTEX, 2021, 38(3): 451-462.
|
29. |
Takai A, Yamaguchi M, Yoshida H, et al. Investigating developmental and epileptic encephalopathy using drosophila melanogaster. Int J Mol Sci, 2020, 21(17): 6442.
|
30. |
Çarçak N, Onat F, Sitnikova E, et al. Astrocytes as a target for therapeutic strategies in epilepsy: current insights. Front Mol Neurosci, 2023, 31(16): 1183775.
|
31. |
Gawel K, Langlois M, Martins T, et al. Seizing the moment: zebrafish epilepsy models. Neurosci Biobehav Rev, 2020, 116: 1-20.
|
32. |
D'Amora M, Galgani A, Marchese M, et al. Zebrafish as an innovative tool for epilepsy modeling: state of the art and potential future directions. Int J Mol Sci, 2023, 2224(9): 7702.
|
33. |
Tiraboschi E, Martina S, van der Ent W, et al. New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome. Epilepsia, 2020, 61(3): 549-560.
|
34. |
Suo G, Cao X, Zheng Y, et al. A de novo nonsense mutation of STXBP1 causes early-onset epileptic encephalopathy. Epilepsy Behav, 2021, 123: 108245.
|
35. |
Deshpande LS, DeLorenzo RJ, Churn SB, et al. Neuronal-specific inhibition of endoplasmic reticulum Mg 2+/Ca 2+ ATPase Ca 2+ uptake in a mixed primary hippocampal culture model of status epilepticus. Brain Sci, 2020, 10(7): 438.
|
36. |
Hansen SN, Holm A, Kauppinen S, et al. RNA therapeutics for epilepsy: an emerging modality for drug discovery. Epilepsia, 2023, 64(12): 3113-3129.
|